mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.093 |
0.05 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
mRNA |
RDEA119 |
FIMM |
pan-cancer |
AAC |
-0.35 |
0.06 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.06 |